RxDoctor Payments Data

Carolann Kinner, DO

Internal Medicine · Warren, MINPI 1306815089

Payments from drug & device makers

$206in general payments, 2019–2025

Across 9 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$48
  • Optos, Inc.$38
  • Exact Sciences$35
  • Alnylam Pharmaceuticals Inc.$27
  • Lilly USA, LLC$22
  • Pfizer$21
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$16982%
  • Entertainment$3818%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$206 in reported general payments places this provider in the 50th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$77,998
Medicare patients
133
Services billed
1,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$64,212
JanuviaSitagliptin Phosphate33$44,384
RybelsusSemaglutide11$23,937
OzempicSemaglutide16$18,309
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,442
MounjaroTirzepatide13$13,228
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate35$10,162
Tiotropium Bromide11$8,340
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$7,219
Breo ElliptaFluticasone/Vilanterol12$3,862
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$3,543
SymbicortBudesonide/Formoterol Fumarate11$2,527
Albuterol Sulfate HfaAlbuterol Sulfate58$2,147
Potassium Chloride87$1,915
Levothyroxine Sodium152$1,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$64,21255 claims
Novo NordiskRybelsus, Ozempic$48$42,24627 claims
Lilly USA, LLCMounjaro$22$13,22813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →